Skip to main content
Top
Published in: Basic Research in Cardiology 4/2016

01-07-2016 | Original Contribution

Nitroglycerin induces DNA damage and vascular cell death in the setting of nitrate tolerance

Authors: Yuliya Mikhed, Jörg Fahrer, Matthias Oelze, Swenja Kröller-Schön, Sebastian Steven, Philipp Welschof, Elena Zinßius, Paul Stamm, Fatemeh Kashani, Siyer Roohani, Joana Melanie Kress, Elisabeth Ullmann, Lan P. Tran, Eberhard Schulz, Bernd Epe, Bernd Kaina, Thomas Münzel, Andreas Daiber

Published in: Basic Research in Cardiology | Issue 4/2016

Login to get access

Abstract

Nitroglycerin (GTN) and other organic nitrates are widely used vasodilators. Their side effects are development of nitrate tolerance and endothelial dysfunction. Given the potential of GTN to induce nitro-oxidative stress, we investigated the interaction between nitro-oxidative DNA damage and vascular dysfunction in experimental nitrate tolerance. Cultured endothelial hybridoma cells (EA.hy 926) and Wistar rats were treated with GTN (ex vivo: 10–1000 µM; in vivo: 10, 20 and 50 mg/kg/day for 3 days, s.c.). The level of DNA strand breaks, 8-oxoguanine and O 6-methylguanine DNA adducts was determined by Comet assay, dot blot and immunohistochemistry. Vascular function was determined by isometric tension recording. DNA adducts and strand breaks were induced by GTN in cells in vitro in a concentration-dependent manner. GTN in vivo administration leads to endothelial dysfunction, nitrate tolerance, aortic and cardiac oxidative stress, formation of DNA adducts, stabilization of p53 and apoptotic death of vascular cells in a dose-dependent fashion. Mice lacking O 6-methylguanine-DNA methyltransferase displayed more vascular O 6-methylguanine adducts and oxidative stress under GTN therapy than wild-type mice. Although we were not able to prove a causal role of DNA damage in the etiology of nitrate tolerance, the finding of GTN-induced DNA damage such as the mutagenic and toxic adduct O 6-methylguanine, and cell death supports the notion that GTN based therapy may provoke adverse side effects, including endothelial function. Further studies are warranted to clarify whether GTN pro-apoptotic effects are related to an impaired recovery of patients upon myocardial infarction.
Appendix
Available only for authorised users
Literature
1.
go back to reference Andreassi MG, Botto N, Simi S, Casella M, Manfredi S, Lucarelli M, Venneri L, Biagini A, Picano E (2005) Diabetes and chronic nitrate therapy as co-determinants of somatic DNA damage in patients with coronary artery disease. J Mol Med (Berl) 83:279–286. doi:10.1007/s00109-005-0634-8 CrossRef Andreassi MG, Botto N, Simi S, Casella M, Manfredi S, Lucarelli M, Venneri L, Biagini A, Picano E (2005) Diabetes and chronic nitrate therapy as co-determinants of somatic DNA damage in patients with coronary artery disease. J Mol Med (Berl) 83:279–286. doi:10.​1007/​s00109-005-0634-8 CrossRef
2.
4.
go back to reference Bliksoen M, Mariero LH, Torp MK, Baysa A, Ytrehus K, Haugen F, Seljeflot I, Vaage J, Valen G, Stenslokken KO (2016) Extracellular mtDNA activates NF-kappaB via toll-like receptor 9 and induces cell death in cardiomyocytes. Basic Res Cardiol 111:42. doi:10.1007/s00395-016-0553-6 CrossRefPubMed Bliksoen M, Mariero LH, Torp MK, Baysa A, Ytrehus K, Haugen F, Seljeflot I, Vaage J, Valen G, Stenslokken KO (2016) Extracellular mtDNA activates NF-kappaB via toll-like receptor 9 and induces cell death in cardiomyocytes. Basic Res Cardiol 111:42. doi:10.​1007/​s00395-016-0553-6 CrossRefPubMed
5.
go back to reference Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schachinger V, Dimmeler S, Zeiher AM (2003) Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108:2212–2218. doi:10.1161/01.CIR.0000095788.78169.AF CrossRefPubMed Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schachinger V, Dimmeler S, Zeiher AM (2003) Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108:2212–2218. doi:10.​1161/​01.​CIR.​0000095788.​78169.​AF CrossRefPubMed
6.
go back to reference Daiber A, Oelze M, August M, Wendt M, Sydow K, Wieboldt H, Kleschyov AL, Munzel T (2004) Detection of superoxide and peroxynitrite in model systems and mitochondria by the luminol analogue L-012. Free Radic Res 38:259–269. doi:10.1080/10715760410001659773 CrossRefPubMed Daiber A, Oelze M, August M, Wendt M, Sydow K, Wieboldt H, Kleschyov AL, Munzel T (2004) Detection of superoxide and peroxynitrite in model systems and mitochondria by the luminol analogue L-012. Free Radic Res 38:259–269. doi:10.​1080/​1071576041000165​9773 CrossRefPubMed
7.
go back to reference Daiber A, Oelze M, Coldewey M, Bachschmid M, Wenzel P, Sydow K, Wendt M, Kleschyov AL, Stalleicken D, Ullrich V, Mulsch A, Munzel T (2004) Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol 66:1372–1382. doi:10.1124/mol.104.002600 CrossRefPubMed Daiber A, Oelze M, Coldewey M, Bachschmid M, Wenzel P, Sydow K, Wendt M, Kleschyov AL, Stalleicken D, Ullrich V, Mulsch A, Munzel T (2004) Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol 66:1372–1382. doi:10.​1124/​mol.​104.​002600 CrossRefPubMed
8.
go back to reference Daiber A, Oelze M, Sulyok S, Coldewey M, Schulz E, Treiber N, Hink U, Mulsch A, Scharffetter-Kochanek K, Munzel T (2005) Heterozygous deficiency of manganese superoxide dismutase in mice (Mn-SOD+/−): a novel approach to assess the role of oxidative stress for the development of nitrate tolerance. Mol Pharmacol 68:579–588. doi:10.1124/mol.105.011585 PubMed Daiber A, Oelze M, Sulyok S, Coldewey M, Schulz E, Treiber N, Hink U, Mulsch A, Scharffetter-Kochanek K, Munzel T (2005) Heterozygous deficiency of manganese superoxide dismutase in mice (Mn-SOD+/−): a novel approach to assess the role of oxidative stress for the development of nitrate tolerance. Mol Pharmacol 68:579–588. doi:10.​1124/​mol.​105.​011585 PubMed
9.
go back to reference Davidson A, Veillard AS, Tognela A, Chan MM, Hughes BG, Boyer M, Briscoe K, Begbie S, Abdi E, Crombie C, Long J, Boyce A, Lewis CR, Varma S, Broad A, Muljadi N, Chinchen S, Espinoza D, Coskinas X, Pavlakis N, Millward M, Stockler MR, Australasian Lung cancer Trials G, Australasian Lung cancer Trials Group A (2015) A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial. Ann Oncol 26:2280–2286. doi:10.1093/annonc/mdv373 CrossRefPubMed Davidson A, Veillard AS, Tognela A, Chan MM, Hughes BG, Boyer M, Briscoe K, Begbie S, Abdi E, Crombie C, Long J, Boyce A, Lewis CR, Varma S, Broad A, Muljadi N, Chinchen S, Espinoza D, Coskinas X, Pavlakis N, Millward M, Stockler MR, Australasian Lung cancer Trials G, Australasian Lung cancer Trials Group A (2015) A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial. Ann Oncol 26:2280–2286. doi:10.​1093/​annonc/​mdv373 CrossRefPubMed
10.
go back to reference DiFabio JM, Thomas GR, Zucco L, Kuliszewski MA, Bennett BM, Kutryk MJ, Parker JD (2006) Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival. J Pharmacol Exp Ther 318:117–123. doi:10.1124/jpet.106.102129 CrossRefPubMed DiFabio JM, Thomas GR, Zucco L, Kuliszewski MA, Bennett BM, Kutryk MJ, Parker JD (2006) Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival. J Pharmacol Exp Ther 318:117–123. doi:10.​1124/​jpet.​106.​102129 CrossRefPubMed
12.
go back to reference Edgell CJ, McDonald CC, Graham JB (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80:3734–3737CrossRefPubMedPubMedCentral Edgell CJ, McDonald CC, Graham JB (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80:3734–3737CrossRefPubMedPubMedCentral
14.
go back to reference Fahrer J, Frisch J, Nagel G, Kraus A, Dorsam B, Thomas AD, Reissig S, Waisman A, Kaina B (2015) DNA repair by MGMT, but not AAG, causes a threshold in alkylation-induced colorectal carcinogenesis. Carcinogenesis 36:1235–1244. doi:10.1093/carcin/bgv114 CrossRefPubMed Fahrer J, Frisch J, Nagel G, Kraus A, Dorsam B, Thomas AD, Reissig S, Waisman A, Kaina B (2015) DNA repair by MGMT, but not AAG, causes a threshold in alkylation-induced colorectal carcinogenesis. Carcinogenesis 36:1235–1244. doi:10.​1093/​carcin/​bgv114 CrossRefPubMed
15.
go back to reference Fahrer J, Huelsenbeck J, Jaurich H, Dorsam B, Frisan T, Eich M, Roos WP, Kaina B, Fritz G (2014) Cytolethal distending toxin (CDT) is a radiomimetic agent and induces persistent levels of DNA double-strand breaks in human fibroblasts. DNA Repair (Amst) 18:31–43. doi:10.1016/j.dnarep.2014.03.002 CrossRef Fahrer J, Huelsenbeck J, Jaurich H, Dorsam B, Frisan T, Eich M, Roos WP, Kaina B, Fritz G (2014) Cytolethal distending toxin (CDT) is a radiomimetic agent and induces persistent levels of DNA double-strand breaks in human fibroblasts. DNA Repair (Amst) 18:31–43. doi:10.​1016/​j.​dnarep.​2014.​03.​002 CrossRef
17.
go back to reference Fan Q, Gao F, Zhang L, Christopher TA, Lopez BL, Ma XL (2005) Nitrate tolerance aggravates postischemic myocardial apoptosis and impairs cardiac functional recovery after ischemia. Apoptosis 10:1235–1242. doi:10.1007/s10495-005-1455-5 CrossRefPubMed Fan Q, Gao F, Zhang L, Christopher TA, Lopez BL, Ma XL (2005) Nitrate tolerance aggravates postischemic myocardial apoptosis and impairs cardiac functional recovery after ischemia. Apoptosis 10:1235–1242. doi:10.​1007/​s10495-005-1455-5 CrossRefPubMed
20.
go back to reference Freedman SB, Daxini BV, Noyce D, Kelly DT (1995) Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period. J Am Coll Cardiol 25:349–355. doi:10.1016/0735-1097(94)00416-N CrossRefPubMed Freedman SB, Daxini BV, Noyce D, Kelly DT (1995) Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period. J Am Coll Cardiol 25:349–355. doi:10.​1016/​0735-1097(94)00416-N CrossRefPubMed
22.
go back to reference Glassner BJ, Weeda G, Allan JM, Broekhof JL, Carls NH, Donker I, Engelward BP, Hampson RJ, Hersmus R, Hickman MJ, Roth RB, Warren HB, Wu MM, Hoeijmakers JH, Samson LD (1999) DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis 14:339–347. doi:10.1093/mutage/14.3.339 CrossRefPubMed Glassner BJ, Weeda G, Allan JM, Broekhof JL, Carls NH, Donker I, Engelward BP, Hampson RJ, Hersmus R, Hickman MJ, Roth RB, Warren HB, Wu MM, Hoeijmakers JH, Samson LD (1999) DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis 14:339–347. doi:10.​1093/​mutage/​14.​3.​339 CrossRefPubMed
23.
go back to reference Green IC, Cunningham JM, Delaney CA, Elphick MR, Mabley JG, Green MH (1994) Effects of cytokines and nitric oxide donors on insulin secretion, cyclic GMP and DNA damage: relation to nitric oxide production. Biochem Soc Trans 22:30–37. doi:10.1042/bst0220030 CrossRefPubMed Green IC, Cunningham JM, Delaney CA, Elphick MR, Mabley JG, Green MH (1994) Effects of cytokines and nitric oxide donors on insulin secretion, cyclic GMP and DNA damage: relation to nitric oxide production. Biochem Soc Trans 22:30–37. doi:10.​1042/​bst0220030 CrossRefPubMed
24.
go back to reference Guarini G, Kiyooka T, Ohanyan V, Pung YF, Marzilli M, Chen YR, Chen CL, Kang PT, Hardwick JP, Kolz CL, Yin L, Wilson GL, Shokolenko I, Dobson JG Jr, Fenton R, Chilian WM (2016) Impaired coronary metabolic dilation in the metabolic syndrome is linked to mitochondrial dysfunction and mitochondrial DNA damage. Basic Res Cardiol 111:29. doi:10.1007/s00395-016-0547-4 CrossRefPubMed Guarini G, Kiyooka T, Ohanyan V, Pung YF, Marzilli M, Chen YR, Chen CL, Kang PT, Hardwick JP, Kolz CL, Yin L, Wilson GL, Shokolenko I, Dobson JG Jr, Fenton R, Chilian WM (2016) Impaired coronary metabolic dilation in the metabolic syndrome is linked to mitochondrial dysfunction and mitochondrial DNA damage. Basic Res Cardiol 111:29. doi:10.​1007/​s00395-016-0547-4 CrossRefPubMed
26.
go back to reference Jabs A, Oelze M, Mikhed Y, Stamm P, Kroller-Schon S, Welschof P, Jansen T, Hausding M, Kopp M, Steven S, Schulz E, Stasch JP, Munzel T, Daiber A (2015) Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats. Vascul Pharmacol 71:181–191. doi:10.1016/j.vph.2015.03.007 CrossRefPubMed Jabs A, Oelze M, Mikhed Y, Stamm P, Kroller-Schon S, Welschof P, Jansen T, Hausding M, Kopp M, Steven S, Schulz E, Stasch JP, Munzel T, Daiber A (2015) Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats. Vascul Pharmacol 71:181–191. doi:10.​1016/​j.​vph.​2015.​03.​007 CrossRefPubMed
28.
go back to reference Kanamasa K, Hayashi T, Kimura A, Ikeda A, Ishikawa K (2002) Long-term, continuous treatment with both oral and transdermal nitrates increases cardiac events in healed myocardial infarction patients. Angiology 53:399–408. doi:10.1177/000331970205300405 CrossRefPubMed Kanamasa K, Hayashi T, Kimura A, Ikeda A, Ishikawa K (2002) Long-term, continuous treatment with both oral and transdermal nitrates increases cardiac events in healed myocardial infarction patients. Angiology 53:399–408. doi:10.​1177/​0003319702053004​05 CrossRefPubMed
29.
go back to reference Kiziltepe T, Hideshima T, Ishitsuka K, Ocio EM, Raje N, Catley L, Li CQ, Trudel LJ, Yasui H, Vallet S, Kutok JL, Chauhan D, Mitsiades CS, Saavedra JE, Wogan GN, Keefer LK, Shami PJ, Anderson KC (2007) JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells. Blood 110:709–718. doi:10.1182/blood-2006-10-052845 CrossRefPubMedPubMedCentral Kiziltepe T, Hideshima T, Ishitsuka K, Ocio EM, Raje N, Catley L, Li CQ, Trudel LJ, Yasui H, Vallet S, Kutok JL, Chauhan D, Mitsiades CS, Saavedra JE, Wogan GN, Keefer LK, Shami PJ, Anderson KC (2007) JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells. Blood 110:709–718. doi:10.​1182/​blood-2006-10-052845 CrossRefPubMedPubMedCentral
30.
go back to reference Kleinbongard P, Thielmann M, Jakob H, Peters J, Heusch G, Kottenberg E (2013) Nitroglycerin does not interfere with protection by remote ischemic preconditioning in patients with surgical coronary revascularization under isoflurane anesthesia. Cardiovasc Drugs Ther 27:359–361. doi:10.1007/s10557-013-6451-3 CrossRefPubMed Kleinbongard P, Thielmann M, Jakob H, Peters J, Heusch G, Kottenberg E (2013) Nitroglycerin does not interfere with protection by remote ischemic preconditioning in patients with surgical coronary revascularization under isoflurane anesthesia. Cardiovasc Drugs Ther 27:359–361. doi:10.​1007/​s10557-013-6451-3 CrossRefPubMed
31.
go back to reference Knorr M, Hausding M, Kroller-Schuhmacher S, Steven S, Oelze M, Heeren T, Scholz A, Gori T, Wenzel P, Schulz E, Daiber A, Munzel T (2011) Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan. Arterioscler Thromb Vasc Biol 31:2223–2231. doi:10.1161/ATVBAHA.111.232058 CrossRefPubMed Knorr M, Hausding M, Kroller-Schuhmacher S, Steven S, Oelze M, Heeren T, Scholz A, Gori T, Wenzel P, Schulz E, Daiber A, Munzel T (2011) Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan. Arterioscler Thromb Vasc Biol 31:2223–2231. doi:10.​1161/​ATVBAHA.​111.​232058 CrossRefPubMed
32.
go back to reference Kroller-Schon S, Steven S, Kossmann S, Scholz A, Daub S, Oelze M, Xia N, Hausding M, Mikhed Y, Zinssius E, Mader M, Stamm P, Treiber N, Scharffetter-Kochanek K, Li H, Schulz E, Wenzel P, Munzel T, Daiber A (2014) Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models. Antioxid Redox Signal 20:247–266. doi:10.1089/ars.2012.4953 CrossRefPubMedPubMedCentral Kroller-Schon S, Steven S, Kossmann S, Scholz A, Daub S, Oelze M, Xia N, Hausding M, Mikhed Y, Zinssius E, Mader M, Stamm P, Treiber N, Scharffetter-Kochanek K, Li H, Schulz E, Wenzel P, Munzel T, Daiber A (2014) Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models. Antioxid Redox Signal 20:247–266. doi:10.​1089/​ars.​2012.​4953 CrossRefPubMedPubMedCentral
40.
go back to reference Munzel T, Li H, Mollnau H, Hink U, Matheis E, Hartmann M, Oelze M, Skatchkov M, Warnholtz A, Duncker L, Meinertz T, Forstermann U (2000) Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res 86:E7–E12. doi:10.1161/01.RES.86.1.e7 CrossRefPubMed Munzel T, Li H, Mollnau H, Hink U, Matheis E, Hartmann M, Oelze M, Skatchkov M, Warnholtz A, Duncker L, Meinertz T, Forstermann U (2000) Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res 86:E7–E12. doi:10.​1161/​01.​RES.​86.​1.​e7 CrossRefPubMed
41.
go back to reference Munzel T, Mollnau H, Hartmann M, Geiger C, Oelze M, Warnholtz A, Yehia AH, Forstermann U, Meinertz T (2000) Effects of a nitrate-free interval on tolerance, vasoconstrictor sensitivity and vascular superoxide production. J Am Coll Cardiol 36:628–634. doi:10.1016/S0735-1097(00)00754-3 CrossRefPubMed Munzel T, Mollnau H, Hartmann M, Geiger C, Oelze M, Warnholtz A, Yehia AH, Forstermann U, Meinertz T (2000) Effects of a nitrate-free interval on tolerance, vasoconstrictor sensitivity and vascular superoxide production. J Am Coll Cardiol 36:628–634. doi:10.​1016/​S0735-1097(00)00754-3 CrossRefPubMed
42.
go back to reference Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG (1995) Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 95:187–194. doi:10.1172/JCI117637 CrossRefPubMedPubMedCentral Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG (1995) Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 95:187–194. doi:10.​1172/​JCI117637 CrossRefPubMedPubMedCentral
44.
go back to reference Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C (1999) Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group. Am Heart J 138:577–585. doi:10.1016/S0002-8703(99)70163-8 CrossRefPubMed Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C (1999) Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group. Am Heart J 138:577–585. doi:10.​1016/​S0002-8703(99)70163-8 CrossRefPubMed
45.
go back to reference Nehls P, Adamkiewicz J, Rajewsky MF (1984) Immuno-slot-blot: a highly sensitive immunoassay for the quantitation of carcinogen-modified nucleosides in DNA. J Cancer Res Clin Oncol 108:23–29. doi:10.1007/BF00390969 CrossRefPubMed Nehls P, Adamkiewicz J, Rajewsky MF (1984) Immuno-slot-blot: a highly sensitive immunoassay for the quantitation of carcinogen-modified nucleosides in DNA. J Cancer Res Clin Oncol 108:23–29. doi:10.​1007/​BF00390969 CrossRefPubMed
46.
go back to reference Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U, Schulz E, Mollnau H, von Sandersleben A, Kleschyov AL, Mulsch A, Li H, Forstermann U, Munzel T (2006) Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 48:677–684. doi:10.1161/01.HYP.0000239207.82326.29 CrossRefPubMed Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U, Schulz E, Mollnau H, von Sandersleben A, Kleschyov AL, Mulsch A, Li H, Forstermann U, Munzel T (2006) Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 48:677–684. doi:10.​1161/​01.​HYP.​0000239207.​82326.​29 CrossRefPubMed
47.
go back to reference Oelze M, Knorr M, Kroller-Schon S, Kossmann S, Gottschlich A, Rummler R, Schuff A, Daub S, Doppler C, Kleinert H, Gori T, Daiber A, Munzel T (2013) Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression. Eur Heart J 34:3206–3216. doi:10.1093/eurheartj/ehs100 CrossRefPubMed Oelze M, Knorr M, Kroller-Schon S, Kossmann S, Gottschlich A, Rummler R, Schuff A, Daub S, Doppler C, Kleinert H, Gori T, Daiber A, Munzel T (2013) Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression. Eur Heart J 34:3206–3216. doi:10.​1093/​eurheartj/​ehs100 CrossRefPubMed
50.
go back to reference Redfield MM, Anstrom KJ, Levine JA, Koepp GA, Borlaug BA, Chen HH, LeWinter MM, Joseph SM, Shah SJ, Semigran MJ, Felker GM, Cole RT, Reeves GR, Tedford RJ, Tang WH, McNulty SE, Velazquez EJ, Shah MR, Braunwald E, Network NHFCR (2015) Isosorbide mononitrate in heart failure with preserved ejection fraction. N Engl J Med 373:2314–2324. doi:10.1056/NEJMoa1510774 CrossRefPubMedPubMedCentral Redfield MM, Anstrom KJ, Levine JA, Koepp GA, Borlaug BA, Chen HH, LeWinter MM, Joseph SM, Shah SJ, Semigran MJ, Felker GM, Cole RT, Reeves GR, Tedford RJ, Tang WH, McNulty SE, Velazquez EJ, Shah MR, Braunwald E, Network NHFCR (2015) Isosorbide mononitrate in heart failure with preserved ejection fraction. N Engl J Med 373:2314–2324. doi:10.​1056/​NEJMoa1510774 CrossRefPubMedPubMedCentral
52.
go back to reference Schuhmacher S, Foretz M, Knorr M, Jansen T, Hortmann M, Wenzel P, Oelze M, Kleschyov AL, Daiber A, Keaney JF Jr, Wegener G, Lackner K, Munzel T, Viollet B, Schulz E (2011) alpha1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation. Arterioscler Thromb Vasc Biol 31:560–566. doi:10.1161/ATVBAHA.110.219543 CrossRefPubMedPubMedCentral Schuhmacher S, Foretz M, Knorr M, Jansen T, Hortmann M, Wenzel P, Oelze M, Kleschyov AL, Daiber A, Keaney JF Jr, Wegener G, Lackner K, Munzel T, Viollet B, Schulz E (2011) alpha1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation. Arterioscler Thromb Vasc Biol 31:560–566. doi:10.​1161/​ATVBAHA.​110.​219543 CrossRefPubMedPubMedCentral
56.
go back to reference Sunjog K, Kolarevic S, Heberger K, Gacic Z, Knezevic-Vukcevic J, Vukovic-Gacic B, Lenhardt M (2013) Comparison of comet assay parameters for estimation of genotoxicity by sum of ranking differences. Anal Bioanal Chem 405:4879–4885. doi:10.1007/s00216-013-6909-y CrossRefPubMed Sunjog K, Kolarevic S, Heberger K, Gacic Z, Knezevic-Vukcevic J, Vukovic-Gacic B, Lenhardt M (2013) Comparison of comet assay parameters for estimation of genotoxicity by sum of ranking differences. Anal Bioanal Chem 405:4879–4885. doi:10.​1007/​s00216-013-6909-y CrossRefPubMed
57.
58.
go back to reference Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M, Ullrich V, Mulsch A, Schulz E, Keaney JF Jr, Stamler JS, Munzel T (2004) Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 113:482–489. doi:10.1172/JCI19267 CrossRefPubMedPubMedCentral Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M, Ullrich V, Mulsch A, Schulz E, Keaney JF Jr, Stamler JS, Munzel T (2004) Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 113:482–489. doi:10.​1172/​JCI19267 CrossRefPubMedPubMedCentral
59.
60.
go back to reference Wenzel P, Mollnau H, Oelze M, Schulz E, Wickramanayake JM, Muller J, Schuhmacher S, Hortmann M, Baldus S, Gori T, Brandes RP, Munzel T, Daiber A (2008) First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid Redox Signal 10:1435–1447. doi:10.1089/ars.2007.1969 CrossRefPubMed Wenzel P, Mollnau H, Oelze M, Schulz E, Wickramanayake JM, Muller J, Schuhmacher S, Hortmann M, Baldus S, Gori T, Brandes RP, Munzel T, Daiber A (2008) First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid Redox Signal 10:1435–1447. doi:10.​1089/​ars.​2007.​1969 CrossRefPubMed
62.
go back to reference Yasuda H, Yamaya M, Nakayama K, Sasaki T, Ebihara S, Kanda A, Asada M, Inoue D, Suzuki T, Okazaki T, Takahashi H, Yoshida M, Kaneta T, Ishizawa K, Yamanda S, Tomita N, Yamasaki M, Kikuchi A, Kubo H, Sasaki H (2006) Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer. J Clin Oncol 24:688–694. doi:10.1200/JCO.2005.04.0436 CrossRefPubMed Yasuda H, Yamaya M, Nakayama K, Sasaki T, Ebihara S, Kanda A, Asada M, Inoue D, Suzuki T, Okazaki T, Takahashi H, Yoshida M, Kaneta T, Ishizawa K, Yamanda S, Tomita N, Yamasaki M, Kikuchi A, Kubo H, Sasaki H (2006) Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer. J Clin Oncol 24:688–694. doi:10.​1200/​JCO.​2005.​04.​0436 CrossRefPubMed
Metadata
Title
Nitroglycerin induces DNA damage and vascular cell death in the setting of nitrate tolerance
Authors
Yuliya Mikhed
Jörg Fahrer
Matthias Oelze
Swenja Kröller-Schön
Sebastian Steven
Philipp Welschof
Elena Zinßius
Paul Stamm
Fatemeh Kashani
Siyer Roohani
Joana Melanie Kress
Elisabeth Ullmann
Lan P. Tran
Eberhard Schulz
Bernd Epe
Bernd Kaina
Thomas Münzel
Andreas Daiber
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
Basic Research in Cardiology / Issue 4/2016
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI
https://doi.org/10.1007/s00395-016-0571-4

Other articles of this Issue 4/2016

Basic Research in Cardiology 4/2016 Go to the issue